Subscribe for perks & to support LI

Your Interests & Preferences: Personalise your reading

Which best describes your role and/or interests?

I work in a law firm
I work for a company / in-house
I'm a litigator at the bar
I'm a law student
Aspiring law student
Other
Save setting
Or click here to show more preferences...

I am interested in the following types of stories (uncheck to hide from frontpage)

Firms / In-House
Deals
Courts
Legal Education

Always show me: (overrides the above)

Exclusives & Editor's Picks

Website Look & Feel

Light Text on Dark Background

Save preferences


Note: Your preferences will be saved in your browser. You can always change your settings by clicking the Your Preferences button at the top of every page.

Reset preferences to defaults?

Veritas, DSK act on $90m Glenmark orthopaedic, pain biz to True North

“Private equity firm True North (formerly known as India Value Fund Advisors) has inked a deal to buy Glenmark Pharmaceuticals Ltd’s orthopaedic and pain management business in India and Nepal, valuing the business at Rs 635 crore ($90 million), the drugmaker said. Glenmark did not disclose if it would hold any stake in the business, which would be transferred to a new entity to be incorporated by True North. This new entity is likely to be named as Integrace Pvt Ltd and will market the product portfolio in India and Nepal,” reported VCCircle.

Veritas Legal advised Glenmark Pharmaceuticals Limited led by a team of partner Abhijit Joshi, partner Tushar Raut, senior associate Somrita Chatterji and associate Anish Patel.

Also advising was DSK Legal.

2018-08-10

Deal value: Rs 63.5 crore

This deal report is based on a firm's press release and may be only partially complete. Some firms or names of advisers may be therefore be missing.

Click here if you are working with a law firm that has not been credited for this deal, and we will update the report promptly.


Latest comments